InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

- Current share price for MVP : $0.475

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$54 FY23 Full Year Results Investor Presentation 31 Aug 2023 8:09AM $0.925 $0.475 fallen by 48.65%
$54 MVP Announces FY23 Full Year Results 31 Aug 2023 8:09AM $0.925 $0.475 fallen by 48.65%
$54 FY23 Full Year Accounts 31 Aug 2023 8:09AM $0.925 $0.475 fallen by 48.65%
$54 Ceasing to be a substantial holder for MVP 28 Aug 2023 5:27PM $1.050 $0.475 fallen by 54.76%
$54 FY23 Full Year Results Announcement Details 15 Aug 2023 1:28PM $1.060 $0.475 fallen by 55.19%
$54 Application for quotation of securities - MVP 3 Aug 2023 3:44PM $1.025 $0.475 fallen by 53.66%
$54 Response to ASX Price Query 26 Jul 2023 8:59AM $1.300 $0.475 fallen by 63.46%
$54 Notification of cessation of securities - MVP 13 Jul 2023 4:47PM $1.215 $0.475 fallen by 60.91%
$54 Notification of cessation of securities - MVP 13 Jul 2023 4:45PM $1.215 $0.475 fallen by 60.91%
$54 Change in substantial holding 15 May 2023 4:59PM $0.775 $0.475 fallen by 38.71%
$54 Final Director's Interest Notice - D. Williams 26 Apr 2023 2:29PM $1.000 $0.475 fallen by 52.50%
$54 Resignation of Director 18 Apr 2023 9:18AM $1.100 $0.475 fallen by 56.82%
$54 US Penthrox Strategy 11 Apr 2023 9:52AM $1.050 $0.475 fallen by 54.76%
$54 S&P DJI Announces March 2023 Quarterly Rebalance 3 Mar 2023 5:03PM $1.450 $0.475 fallen by 67.24%
$54 Confirmation of Half Year Results Presentation Details 24 Feb 2023 10:13AM $1.445 $0.475 fallen by 67.13%
$54 2023 Half Year Presentation 24 Feb 2023 8:55AM $1.370 $0.475 fallen by 65.33%
$54 2023 Half Year ASX Announcement 24 Feb 2023 8:54AM $1.370 $0.475 fallen by 65.33%
$54 2023 Half Year Report (including 4D) 24 Feb 2023 8:54AM $1.370 $0.475 fallen by 65.33%
$54 Half Year Results Announcement Details 6 Feb 2023 3:16PM $1.475 $0.475 fallen by 67.80%
$54 Notification of cessation of securities - MVP 20 Jan 2023 12:50PM $1.615 $0.475 fallen by 70.59%
$54 Notification regarding unquoted securities - MVP 20 Jan 2023 12:48PM $1.635 $0.475 fallen by 70.95%
$54 China Clinical Trials Discontinued 18 Jan 2023 9:06AM $1.670 $0.475 fallen by 71.56%
$54 Annual General Meeting - Recording available 28 Oct 2022 1:03PM $1.630 $0.475 fallen by 70.86%
$54 Results of Meeting 27 Oct 2022 4:28PM $1.670 $0.475 fallen by 71.56%
$54 Final Director's Interest Notice - M. Johnston 27 Oct 2022 3:11PM $1.683 $0.475 fallen by 71.77%

126 - 150 of 619 results

Page 6 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.